Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
Public ClinicalTrials.gov record NCT00744939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Non-randomized Observational (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Magnevist® Injection in Patients With Moderate Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Assess potential risk for NSF in subjects with renal impairment (moderate) post magnevist injection. Subjects will be screened within 48 hours of previously scheduled MRI, those meeting the enrollment criteria will be enrolled prior to MRI and followed for 2 years post MRI with visits occuring at 1yr and 2 yr timepoints, in addition follow-up phone calls conducted at 1, 3, 6 and 18 months to assess for skin changes suggestive of NSF.
Study identification
- NCT ID
- NCT00744939
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Jul 2013 (Actual)
- Completion
- Nov 2013 (Actual)
- Last update posted
- Sep 22, 2014
2008 – 2013
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85008 | — |
| Not listed | Chula Vista | California | 91910 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Santa Rosa | California | 95405 | — |
| Not listed | Pueblo | Colorado | 81008 | — |
| Not listed | New Haven | Connecticut | 06520--804 | — |
| Not listed | Jacksonville | Florida | 32209-6595 | — |
| Not listed | Honolulu | Hawaii | 96813 | — |
| Not listed | Honolulu | Hawaii | 96859 | — |
| Not listed | Topeka | Kansas | 66604 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Boston | Massachusetts | 02118 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Brooklyn | New York | 11219 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Stony Brook | New York | 11790 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Danville | Pennsylvania | 17822-2001 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Memphis | Tennessee | 38104 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Tacoma | Washington | 98321 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00744939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 22, 2014 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00744939 live on ClinicalTrials.gov.